At what point, and under what circumstances, should trial participation be allowed to proceed without some discussion of consent? And how extensive should that discussion …
At a time when so many aspects of our everyday lives are influenced and enhanced by digital technology, it is clear the momentum in global mobile communications …
Given the increased number of global regulatory and standards-based guidance documents issued over recent years, members of the pharmaceutical supply chain are taking notice and making changes …
Healthcare is moving towards a patient-centric model, demanding a corresponding shift in clinical research design to reflect the incorporation of the voice of the patient. Jennifer Harrell …
Melanoma, arising predominantly from clonally multiplying pigment cells, may rapidly become metastatic and spread to secondary organs (the lungs, liver, brain, pleura). In their study, K.Värv, R. Rumvolt, …
Are there more drugs approved? Is the regulatory pathway to getting a drug to market as a treatment for HD any easier? Has there been any …
South Africa is considered a clinical research “hot spot” due to its diverse genetic, drug-naive patient population, known for supplying high-quality data across all phases of …
All sub-Saharan countries, including Botswana, South Africa and Zimbabwe, face a severe HIV and AIDS epidemic. As many authors have already suggested, one solution to …
Matan Topper-Erez of TransCom Global explores the challenges raised by conducting clinical trials in Israel, an ever-popular destination for multinational clinical trials, and its unique multilingual landscape. …
Readers of previous articles in this series have seen John Faulkes of Agio Interactive discuss a range of critical factors that are instrumental in whether …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
